Abstract
Dilated cardiomyopathy is a disease of unknown etiology that principally affects the myocardium [1]. The diagnosis of dilated cardiomyopathy is established by the presence of left ventricular dilatation and systolic dysfunction in the absence of congenital, coronary, valvular, or pericardial heart disease [2]. In some patients the development of dilated cardiomyopathy is associated with clinical factors such as alcoholism, pregnancy or a family history of cardiomyopathy [1,2]. However, dilated cardiomyopathy is distinct from specific heart muscle disease (“secondary myocardial disease”), which occurs with a specific systemic disorder that may be metabolic, collagen-vascular, infiltrative, neuromuscular, inflammatory, or neoplastic in origin [1, 2] (see Chap. 1). There are currently no specific gross anatomic, histologic, or ultrastructural morphologic features which can differentiate dilated cardiomyopathy from other causes of heart failure [3]. Since dilated cardiomyopathy is defined clinically, it is likely that several specific etiologies are responsible for this condition. It is therefore not surprising that patients with dilated cardiomyopathy have a heterogeneous clinical presentation and prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shabetai R (1983) Cardiomyopathy: how far have we come in 25 years, how far yet to go? J Am Coll Cardiol 1: 252–263
Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult. N Engl J Med 307: 1051–1058
Silver MA (1988) Anatomy of the failing heart in dilated cardiomyopathy. In: Engelmeier RS, O’Connell JB (eds) Drug therapy in dilated cardiomyopathy and myocarditis. Dekker,New York, pp 1–12
McKee PA, Castelli UP, McNamara PM et al. (1971). The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441–1446
Torp A (1978) Incidence of congestive cardiomyopathy. Postgrad Med J 54: 435–437
Gavazzi A, Lanzarini L, Cornalba C, Desperati M, Raisaro A, Angoli L, de Servi S, Specchia G (1984) Dilated (congestive) cardiomyopathy. G ltal Cardiol 14: 492–498
Gorlin R (1983) Incidence, etiology and prognosis of heart failure. Cardiovasc Rev Rep 4: 765
Fuster V, Gersh BJ, Giuliana ER, Tajik AJ, Brandenburg RO, Frye RL, (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525
Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H (1988) Modle of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 116: 1455
Diaz RA, Obasohan A, Oakley CM et al. (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58: 393–399
O’Connell JB, Costanzo-Nordin MR, Engelmeier RS, Wallis DE, Robinson JA, Scanlon PJ (1985) Prognosis and treatment of cardiomyopathy and myocarditis. Heart Vessels 1 Suppl I: 175–179
Unverferth DV, Magorien RD, Mosechberger ML, Baker PB, Fetters JK, Leier CV (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152
Franciosa JA,Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51: 831–836
Figulla HR, Rahlf G, Nieger M, Luig H, Kreuzer H (1985). Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 71: 1095–1104
Convert G, Delaye J, Beaune J, Biron A, Gonin A (1980). Etude pronostique des myocardiopathies primitive non obstructives. Arch Mal Coeur 27: 22T - 237
Lengyel M, Kokeny M (1981) Follow-up study in congestive (dilated) cardiomyopathy. Acta Cardiol 1: 35–48
Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner E-RV, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53: 902–907
Romeo F, Pelliccia F, Cianfrocca C, Cristofani R, Reale A (1989) Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 63: 138–140
Koide T, Kato A, Takabatake Y, Iizuka M, Uchida Y, Ozeki K, Morooka S, Kakihana M, Serizawa T, Tanaka S, Ohya T, Momomura S, Murao S (1980) Variable prognosis in congestive cardiomyopathy: role of left ventricular function, alcoholism, and pulmonary thrombosis. Jpn Heart J 21: 451–463
Stevenson LW, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V (1987) Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med 83: 871–876
Keogh AM, Freund J, Baron DW, Hickie JB (1988) Timing of cardiac transplantation in idiopathic dilated cardiomyopathy. Am J Cardiol 61: 418–422
Kuhn H, Becker R, Fischer J, Curtius JM, Losse B, Hort W, Loogen F (1982)Untersuchungen zur Atiologie, zum Verlauf and zur Prognose der dilatativen Kardiomyopathie (DCM). Z Kardiol 71: 497–508
Strain JE, Grose RM, Cho S, Factor SM (1985) Short term natural history of untreated myocarditis (Abstr). Circulation 72-III: 110
Quigley PJ, Richardson PJ, Meany BT, Olsen EGJ,Monaghan M, Jackson G, Jewitt DE (1987) Long term follow up in biopsy proven myocarditis: progression to dilated cardiomyopathy. Br Heart J 57: 71
Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM (1971) Natural course of peripartum cardiomyopathy. Circulation 44: 1053–1061
DeMakis JG, Proskey A, Rahimtoola SH, Jamil M, Sutton GC, Rosen KM, Gunnar RM, Tobin JR (1974) The natural course of alcoholic cardiomyopathy. Ann Intern Med 80: 293–297
Schwartz L, Sample KA, Wigle ED (1975) Severe alcoholic cardiomyopathy reversed with abstention from alcohol. Am J Cardiol 36: 963–966
Costanzo-Nordin MR, O’Connell JB, Engelmeier RS, Moran JF, Scanlon PJ (1985) Dilated cardiomyopathy: functional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc Diagn 11: 445–453
Olshausen AV, Stienen U, Schwarz F, Kubler W, Meyer J (1988) Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 61: 146–151
Holmes J, Kubo SH, Cody RJ, Kligfield P (1985) Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 55: 146–151
Das SK, Mordy F, DiCarlo L, Baerman J, Krol R, de Buitleir M, Crevey B (1986) Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 58: 998–1000
Poll DS, Marchlinski FE, Buxton AE, Josephson ME (1986) Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 58: 992–997
Baandrup U, Florio RA, Rehahn M, Richardson PJ, Olsen EGJ (1981) Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. Br Heart J 45: 487–493
Hammond EH, Menlove RL, Anderson JL (1987) Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 114: 1055
Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin—angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C-S, Kubo SH, RudinToretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82: 1724–1729
Maisel AS, Scott NA, Motulsky Hi, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR (1989) Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med 86: 43
Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823
Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L (1990) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82: 1730–1736
Lee WH, Packer M (1986) Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 73: 257–267
Mason JW, Billinggham ME, Ricci DR (1980) Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 45: 1037–1044
Gilbert EM, Mason JW Immunosuppressive therapy of myocarditis. In: Engelmeier RS, O’Connell JB (eds) Drug therapy in dilated cardiomyopathy and myocarditis. Dekker, New York, pp 233–263
Doherty JE (1988) Use of digitalis and diuretics in the treatment of heart failure. In: Cohn JN (ed) Drug treatment of heart failure. Advanced Therapeutics Communications International, Secaucus, pp 147–178
Renlin FC The actions and use of diuretics in renal disease. In: Freidkey CK (ed) Heart, kidney and electrolytes. Grune and Stratton, New York, pp 169–193
Craswell PW, Ezzati E, Kopstein J et al. (1973) Use of metolazone, a new diuretic, in patients with renal disease. Nephron 12: 63–73
CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435
Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. N. Engl J Med 314: 1547–1552
Cody RJ, Franklin KW, Kluger J, Laugh LH (1982) Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Am J Med 72: 791–797
Cleland JGF, Dangic H, Horsman GP et al. (1984) Captopril in heart failure, a double blind controlled trial. Br Heart J 52: 530–535
Captopril-Digoxin Multicenter Research Group (1988) Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 259: 539–554
DiBianco R, Shabetai R, Kostuk W et al. (1989) A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320: 677–683
DiBianco R, Shabetai R, Kostuk W et al. (1989) A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320: 677–683
Waagstein F, Hjalmmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37: 1022–1036
Engelmeier RS, O’Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM (1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double blind, randomized, placebo-controlled trial. Circulation 72: 526–546
Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O’Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR (1990) Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 88: 223–229
Gilbert EM, Mestroni L, Anderson JL, Woodley SL, Bristow MR (1989) Can response to beta-blocker therapy in idiopathic dilated cardiomyopathy be predicted by baseline parameters? Circulation 80: 11–428
Swedberg K, Waagstein F, Hjalmarson S, Wallentin I (1979) Prolongation of survival in congestive cardiomyopathy by a beta receptor blockade. Lancet I: 1374–1376
Anderson JL, Lutz JR, Gilbert EM, Sorenson SG, Yanowitz FG, Menlove RL, Batholomew M (1985) A randomized trial of low dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 55: 471–475
O’Connell JB, Renlund DG, Bristow MR (1989) Cardiac transplantation: emerging role of the internist/cardiologist. J Intern Med 225: 147–156
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gilbert, E.M., Di Lenarda, A., O’Connell, J.B. (1993). Prognosis and Management. In: Goodwin, J.F., Olsen, E.G.J. (eds) Cardiomyopathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77598-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-77598-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77600-7
Online ISBN: 978-3-642-77598-7
eBook Packages: Springer Book Archive